5ZQU
Crystal structure of tetrameric RXRalpha-LBD complexed with partial agonist CBt-PMN
5ZQU の概要
エントリーDOI | 10.2210/pdb5zqu/pdb |
分子名称 | Retinoic acid receptor RXR-alpha, 1-(3,5,5,8,8-pentamethyl-6,7-dihydronaphthalen-2-yl)benzotriazole-5-carboxylic acid, BROMIDE ION, ... (4 entities in total) |
機能のキーワード | extended form, multiple conformation, nuclear receptor, retinoid x receptor, transcription |
由来する生物種 | Homo sapiens (Human) |
タンパク質・核酸の鎖数 | 4 |
化学式量合計 | 111556.83 |
構造登録者 | Miyashita, Y.,Numoto, N.,Arulmozhiraja, S.,Nakano, S.,Matsuo, N.,Shimizu, K.,Kakuta, H.,Ito, S.,Ikura, T.,Ito, N.,Tokiwa, H. (登録日: 2018-04-20, 公開日: 2019-02-27, 最終更新日: 2024-10-16) |
主引用文献 | Miyashita, Y.,Numoto, N.,Arulmozhiraja, S.,Nakano, S.,Matsuo, N.,Shimizu, K.,Shibahara, O.,Fujihara, M.,Kakuta, H.,Ito, S.,Ikura, T.,Ito, N.,Tokiwa, H. Dual conformation of the ligand induces the partial agonistic activity of retinoid X receptor alpha (RXR alpha ). FEBS Lett., 593:242-250, 2019 Cited by PubMed Abstract: 1-[(3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydronaphthalen-2-yl)amino]benzotriazole-5-carboxylic acid (CBt-PMN), a partial agonist of retinoid X receptor (RXR), has attracted attention due to its potential to treat type 2 diabetes and central nervous system diseases with reduced adverse effects of existing full agonists. Herein, we report the crystal structure of CBt-PMN-bound ligand-binding domain of human RXRα (hRXRα) and its biochemical characterization. Interestingly, the structure is a tetramer in nature, in which CBt-PMNs are clearly found binding in two different conformations. The dynamics of the hRXRα/CBt-PMN complex examined using molecular dynamics simulations suggest that the flexibility of the AF-2 interface depends on the conformation of the ligand. These facts reveal that the dual conformation of CBt-PMN in the complex is probably the reason behind its partial agonistic activity. PubMed: 30565665DOI: 10.1002/1873-3468.13301 主引用文献が同じPDBエントリー |
実験手法 | X-RAY DIFFRACTION (2.60038789589 Å) |
構造検証レポート
検証レポート(詳細版)をダウンロード